Affordable Insulin

For the first time, Lilly will supply API at a significantly reduced price along with pro-bono technical assistance, enabling EVA Pharma to manufacture and supply insulin to at least one million people in lower income countries Eli Lilly and Company (NYSE: LLY) and EVA Pharma (https://www.EVAPharma.com/) announced today a collaboration to deliver a sustainable supply […]

...